Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial

Go back to Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
(NASDAQ: CMND) Delayed: 1.71 --0 (-0%)
Previous Close $1.71    52 Week High
Open $1.71    52 Week Low
Day High $1.71    P/E N/A 
Day Low $1.71    EPS
Volume 883